Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis [NA]

View source ↗

Summary

Clinical trial at The Cleveland Clinic is evaluating whether HMB-enriched amino acids can reverse muscle loss in patients with liver cirrhosis; recruitment is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMB Enriched Amino Acids (beta-hydroxy beta-methylbutyrate (HMB) with amino acids)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Cirrhosis, Liver | NA | Status: RECRUITING